Last Updated: May 10, 2026

Details for New Drug Application (NDA): 073588

✉ Email this page to a colleague

« Back to Dashboard

NDA 073588 describes TOLMETIN SODIUM, which is a drug marketed by Ani Pharms, Chartwell Rx, Rising, Senores Pharms, Sun Pharm Industries, and Cosette, and is included in fourteen NDAs. It is available from five suppliers. Additional details are available on the TOLMETIN SODIUM profile page.

The generic ingredient in TOLMETIN SODIUM is tolmetin sodium. There are twelve drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the tolmetin sodium profile page.

Summary for 073588

Tradename:	TOLMETIN SODIUM
Applicant:	Chartwell Rx
Ingredient:	tolmetin sodium
Patents:	0

Pharmacology for NDA: 073588

Mechanism of Action	Cyclooxygenase Inhibitors

Medical Subject Heading (MeSH) Categories for 073588

Anti-Inflammatory Agents, Non-Steroidal
Cyclooxygenase Inhibitors

Suppliers and Packaging for NDA: 073588

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
TOLMETIN SODIUM	tolmetin sodium	TABLET;ORAL	073588	ANDA	Lifsa Drugs LLC	72336-118	72336-118-30	30 TABLET in 1 BOTTLE (72336-118-30)

Profile for product number 001

Active Rx/OTC/Discontinued:	DISCN	Dosage:	TABLET;ORAL			Strength	EQ 200MG BASE
Approval Date:	Jul 31, 1992	TE:		RLD:	No

Complete Access Available with Subscription

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.